The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwHRMM 2024 | The importance of imaging in patients with myeloma with extramedullary disease
Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, discusses the essential role of imaging in diagnosing and managing patients with multiple myeloma (MM) with extramedullary disease (EMD). Imaging is crucial not only for diagnosis but also for assessing therapeutic response, as bone marrow laboratory results alone may not suffice. Current efforts aim to revise response criteria, focusing more on functional imaging over lesion size to provide a more accurate measure of treatment success. This discussion took place at the 1st International Workshop on High-Risk Multiple Myeloma (iwHRMM 2024), held in Charleston, SC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
